Impact of pre-diabetes and diabetes on cardiovascular outcomes

Curr Vasc Pharmacol. 2012 Nov;10(6):680-3. doi: 10.2174/157016112803520882.

Abstract

The present paper examines major evidences on the correlation between pre-diabetes, diabetes and cardiovascular risk, especially focusing on early and multifactorial treatment strategies holding the potential to delay the occurrence of micro- and macro-vascular complications causing impaired quality of life and reduced survival.

Publication types

  • Review

MeSH terms

  • Biomarkers / metabolism
  • Blood Glucose / metabolism
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / etiology*
  • Diabetes Mellitus, Type 2 / mortality
  • Diabetes Mellitus, Type 2 / therapy
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Prediabetic State / blood
  • Prediabetic State / complications*
  • Prediabetic State / mortality
  • Prediabetic State / therapy
  • Prevalence
  • Preventive Health Services
  • Risk Assessment
  • Risk Factors
  • Risk Reduction Behavior
  • Treatment Outcome

Substances

  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • hemoglobin A1c protein, human